Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 7/2007

01-07-2007 | Editorial

Moving Towards Shared Decision Making in Prostate Cancer Screening

Authors: Richard M. Hoffman, MD, MPH, Deborah L. Helitzer, ScD

Published in: Journal of General Internal Medicine | Issue 7/2007

Login to get access

Excerpt

The United States Preventive Services Task Force concluded in 2002 that there is insufficient evidence to recommend for or against routine prostate cancer screening.1 However, the Task Force did recommend that providers discuss the risks and benefits of screening with eligible patients to help them reach an informed decision. The content of such a discussion, comprehensively addressed in focus-group work by Chan and Sulmasy, would encompass the domains of epidemiology, pathophysiology, screening, treatment options, and treatment complications.2 These authors identified over 20 specific relevant items for inclusion in screening discussions. …
Literature
1.
U.S. Preventive Services Task Force. Screening for prostate cancer: recommendation and rationale. Ann Intern Med. 2002;137(11):915–6.
2.
Chan EC, Sulmasy DP. What should men know about prostate-specific antigen screening before giving informed consent? Am J Med. 1998;105(4):266–74.PubMed
3.
Jordan TR, Price JH, King KA, Masyk T, Bedell AW. The validity of male patients’ self-reports regarding prostate cancer screening. Prev Med. 1999;28(3):297–303.PubMed
4.
Chan EC, Vernon SW, Ahn C, Greisinger A. Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites. Am J Public Health. 2004;94(8):1336–8.PubMed
5.
Federman DG, Goyal S, Kamina A, Peduzzi P, Concato J. Informed consent for PSA screening: does it happen? Eff Clin Pract. 1999;2(4):152–7.PubMed
6.
Dunn AS, Shridharani KV, Lou W, Bernstein J, Horowitz CR. Physician–patient discussions of controversial cancer screening tests. Am J Prev Med. 2001;20(2):130–4.PubMed
7.
Guerra CD, Jacobs SE, Holmes J, Shea JA. Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study. J Gen Intern Med. 2007. DOI: 10.​1007/​s11606-007-0142-3.
8.
Ratzan SC, Parker RM. Introduction. In: Seldon CR, Zorn M, Ratzan SC, Parker RM, eds. National Library of Medicine Current Bibliographies in Medicine; Health Literacy. Bethesda, MD: National Institutes of Health, U.S.. Department of Health and Human Issues; 2000.
9.
Institute of Medicine. Health Literacy: A Prescription to End Confusion. Washington, DC: National Academies Press; 2004.
10.
Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH. Informed decision making: what is its role in cancer screening? Cancer. 2004;101(Suppl 5):1214–28.PubMed
11.
Stewart M, Brown JB, Donner A, et al. The impact of patient-centered care on outcomes. J Fam Pract. 2000;49(9):796–804.PubMed
12.
Barry MJ. Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. 2002;136(2):127–35.PubMed
13.
Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93(4):635–41.PubMedCrossRef
Metadata
Title
Moving Towards Shared Decision Making in Prostate Cancer Screening
Authors
Richard M. Hoffman, MD, MPH
Deborah L. Helitzer, ScD
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 7/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0167-7

Other articles of this Issue 7/2007

Journal of General Internal Medicine 7/2007 Go to the issue

Original Article

The Effectiveness of β-blockers in Women With Congestive Heart Failure

Case Reports/Clinical Vignettes

Renal Cell Carcinoma Presenting with Paraneoplastic Hypercalcemic Coma: A Case Report and Review of the Literature

Original Article

Process of Care and Outcomes in Patients with Peripheral Arterial Disease

Populations at Risk

Homeless People’s Perceptions of Welcomeness and Unwelcomeness in Healthcare Encounters

Case Reports/Clinical Vignettes

An Unusual Case of Cardiac Amyloidosis

Original Article

Are Physicians Discussing Prostate Cancer Screening with Their Patients and Why or Why Not? A Pilot Study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits